-
1
-
-
0026725003
-
Long-term results of intravesical therapy for superficial bladder cancer
-
Lamm, D. L.: Long-term results of intravesical therapy for superficial bladder cancer. Urol. Clin. N. Amer., 19: 573, 1992.
-
(1992)
Urol. Clin. N. Amer.
, vol.19
, pp. 573
-
-
Lamm, D.L.1
-
2
-
-
0030002747
-
A combined analysis of European Organisation for Research and Treatment on Cancer and Medical Research Council clinical trials for the prophylactic treatment of stage TaT1 bladder cancer
-
Pawinski, A., Sylvester, R., Kurth, K. H., Bouffioux, C., Van Der Meijden, A., Parmar, M. K. B. and Bijnens, L. for the Members of the European Organisation for Research and Treatment on Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer: A combined analysis of European Organisation for Research and Treatment on Cancer and Medical Research Council clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. J. Urol., 156: 1934, 1996.
-
(1996)
J. Urol.
, vol.156
, pp. 1934
-
-
Pawinski, A.1
Sylvester, R.2
Kurth, K.H.3
Bouffioux, C.4
Van Der Meijden, A.5
Parmar, M.K.B.6
Bijnens, L.7
-
3
-
-
0026045407
-
Intravesical sequential combination of epirubicin and interferon alpha-2b in patients affected by superficial transitional cell carcinoma of the bladder. Results of a pilot study at Palermo University and proposal of a basic research
-
Serretta, V., Corselli, G., Pavone, C., Pizzuto Antinoro, S. A. and Pavone Macaluso, M.: Intravesical sequential combination of epirubicin and Interferon alpha-2b in patients affected by superficial transitional cell carcinoma of the bladder. Results of a pilot study at Palermo University and proposal of a basic research. Prog. Clin. Biol. Res., 370: 185, 1991.
-
(1991)
Prog. Clin. Biol. Res.
, vol.370
, pp. 185
-
-
Serretta, V.1
Corselli, G.2
Pavone, C.3
Pizzuto Antinoro, S.A.4
Pavone Macaluso, M.5
-
4
-
-
0028799851
-
Alternating mitomy-cin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder
-
Rintala, E., Jauhiainen, K., Rajala, P., Ruutu, M., Kaasinen, E., Alfthan, O. and the Finnbladder Group: Alternating mitomy-cin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. J. Urol., 154: 2050, 1995.
-
(1995)
J. Urol.
, vol.154
, pp. 2050
-
-
Rintala, E.1
Jauhiainen, K.2
Rajala, P.3
Ruutu, M.4
Kaasinen, E.5
Alfthan, O.6
-
5
-
-
8944234345
-
Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer
-
Rintala, E., Jauhiainen, K., Kaasinen, E., Nurmi, M., Alfthan, O. and the Finnbladder Group: Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. J. Urol., 156: 56, 1996.
-
(1996)
J. Urol.
, vol.156
, pp. 56
-
-
Rintala, E.1
Jauhiainen, K.2
Kaasinen, E.3
Nurmi, M.4
Alfthan, O.5
-
6
-
-
0029665257
-
Marker tumor responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer Genitourinary group (EORTC 30897)
-
Van Der Meijden, A. P. M., Hall, R. R., Macaluso, M. P., Pawinski, A., Sylvester, R. and Van Glabbeke, M.: Marker tumor responses to the sequential combination of intravesical therapy with mitomycin-C and BCG-RIVM in multiple superficial bladder tumours. Report from the European Organisation for Research and Treatment on Cancer Genitourinary group (EORTC 30897). Eur. Urol., 29: 199, 1996.
-
(1996)
Eur. Urol.
, vol.29
, pp. 199
-
-
Van Der Meijden, A.P.M.1
Hall, R.R.2
Macaluso, M.P.3
Pawinski, A.4
Sylvester, R.5
Van Glabbeke, M.6
-
7
-
-
0018292701
-
Analysis of the principles underlying chemoimmunotherapy of mouse tumours I. Treatment with cyclophosphamide followed by Corynebacterium parvum
-
Scott, M. T.: Analysis of the principles underlying chemoimmunotherapy of mouse tumours I. Treatment with cyclophosphamide followed by Corynebacterium parvum. Cancer Immunol. Immunother., 6: 107, 1979.
-
(1979)
Cancer Immunol. Immunother.
, vol.6
, pp. 107
-
-
Scott, M.T.1
-
8
-
-
0020522785
-
Chemoimmunoprophylaxis of an experimental bladder cancer with retinoids and bacillus Calmette-Guérin
-
Pang, A. S. D. and Morales, A.: Chemoimmunoprophylaxis of an experimental bladder cancer with retinoids and bacillus Calmette-Guérin. J. Urol., 130: 166, 1983.
-
(1983)
J. Urol.
, vol.130
, pp. 166
-
-
Pang, A.S.D.1
Morales, A.2
-
9
-
-
0018647488
-
Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/ BCG treatment on experimental bladder cancer
-
Adolphs, H. D., Thiele, J. and Kiel, H.: Effect of intralesional and systemic BCG-application or a combined cyclophosphamide/ BCG treatment on experimental bladder cancer. Urol. Res., 7: 71, 1979.
-
(1979)
Urol. Res.
, vol.7
, pp. 71
-
-
Adolphs, H.D.1
Thiele, J.2
Kiel, H.3
-
10
-
-
0024377324
-
Mechanisms of action of intravesical BCG for bladder cancer
-
Edited by F. M. J. Debruyne, L. Denis and A. P. M. Van Der Meijden. New York:Alan R. Liss Inc.
-
Ratliff, T. L.: Mechanisms of action of intravesical BCG for bladder cancer. In: EORTC Genito-Urinary Group Monograph 6: BCG in Superficial Bladder Cancer. Edited by F. M. J. Debruyne, L. Denis and A. P. M. Van Der Meijden. New York:Alan R. Liss Inc., pp. 107-122, 1989.
-
(1989)
EORTC Genito-Urinary Group Monograph 6: BCG in Superficial Bladder Cancer
, pp. 107-122
-
-
Ratliff, T.L.1
-
11
-
-
0025604814
-
Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors
-
Hudson, M. A., Yuan, J. J., Catalona, W. J. and Ratliff, T. L.: Adverse impact of fibrin clot inhibitors on intravesical bacillus Calmette-Guerin therapy for superficial bladder tumors. J. Urol., 144: 1362, 1990.
-
(1990)
J. Urol.
, vol.144
, pp. 1362
-
-
Hudson, M.A.1
Yuan, J.J.2
Catalona, W.J.3
Ratliff, T.L.4
-
12
-
-
0024410019
-
Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma
-
Rizzo, M., Bartoletti, R., Selli, C., Sicignano, A. and Criscuolo, D.: Interferon alpha-2a and vinblastine in the treatment of metastatic renal carcinoma. Eur. Urol., 16: 271, 1989.
-
(1989)
Eur. Urol.
, vol.16
, pp. 271
-
-
Rizzo, M.1
Bartoletti, R.2
Selli, C.3
Sicignano, A.4
Criscuolo, D.5
-
13
-
-
0025816155
-
Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancer
-
Welander, C. E., Homesley, H. D. and Barrett, R. J.: Combined interferon alfa and doxorubicin in the treatment of advanced cervical cancer. Amer. J. Obst. Gynec., 165: 284, 1991.
-
(1991)
Amer. J. Obst. Gynec.
, vol.165
, pp. 284
-
-
Welander, C.E.1
Homesley, H.D.2
Barrett, R.J.3
-
14
-
-
0025835507
-
Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: A multicenter phase II study
-
Stoter, G., Aamdal, S., Rodenhuis, S., Cleton, F. J., Iacobelli, S., Franks, C. R., Oskam, R. and Shiloni, E.: Sequential administration of recombinant human interleukin-2 and dacarbazine in metastatic melanoma: a multicenter phase II study. J. Clin. Oncol., 9: 1687, 1991.
-
(1991)
J. Clin. Oncol.
, vol.9
, pp. 1687
-
-
Stoter, G.1
Aamdal, S.2
Rodenhuis, S.3
Cleton, F.J.4
Iacobelli, S.5
Franks, C.R.6
Oskam, R.7
Shiloni, E.8
-
15
-
-
0021293224
-
Physiology of fibronectin
-
Mosher, D. F.: Physiology of fibronectin. Ann. Rev. Med., 35:561, 1984.
-
(1984)
Ann. Rev. Med.
, vol.35
, pp. 561
-
-
Mosher, D.F.1
-
16
-
-
0025101229
-
Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response
-
Kavoussi, L. R., Brown, E. J., Ritchie, J. K. and Ratliff, T. L.: Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response. J. Clin. Invest., 85: 62, 1990.
-
(1990)
J. Clin. Invest.
, vol.85
, pp. 62
-
-
Kavoussi, L.R.1
Brown, E.J.2
Ritchie, J.K.3
Ratliff, T.L.4
-
17
-
-
0028046160
-
Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder
-
Balemans, L. T., Vegt, P. D., Steerenberg, P. A., De Boer, E. C., Van Swaay, A., De Vries, R. E., Van der Meijden, A. P. and Den Otter, W.: Effects of sequential intravesical administration of mitomycin C and bacillus Calmette-Guérin on the immune response in the guinea pig bladder. Urol. Res., 22: 239, 1994.
-
(1994)
Urol. Res.
, vol.22
, pp. 239
-
-
Balemans, L.T.1
Vegt, P.D.2
Steerenberg, P.A.3
De Boer, E.C.4
Van Swaay, A.5
De Vries, R.E.6
Van Der Meijden, A.P.7
Den Otter, W.8
-
18
-
-
0026859019
-
Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: Interferon-alpha 2b versus interferon-alpha 2b with epirubicin
-
Ferrari, P., Castagnetti, G., Pollastri, C. A., Ferrari, G., Tavoni, F. and Grassi, D.: Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin. Anticancer drugs, suppl, 1: 25, 1992.
-
(1992)
Anticancer Drugs
, vol.1
, Issue.SUPPL.
, pp. 25
-
-
Ferrari, P.1
Castagnetti, G.2
Pollastri, C.A.3
Ferrari, G.4
Tavoni, F.5
Grassi, D.6
-
19
-
-
0345222336
-
Frequency and nature of cutaneous reactions to intravesical instillation of mitomycin for superficial bladder cancer
-
de Groot, A., Van der Meijden, A. P. M., Conemans, J. M. H. and Maibach, H. I.: Frequency and nature of cutaneous reactions to intravesical instillation of mitomycin for superficial bladder cancer. Urology, suppl., 40: 16, 1993.
-
(1993)
Urology
, vol.40
, Issue.SUPPL.
, pp. 16
-
-
De Groot, A.1
Van Der Meijden, A.P.M.2
Conemans, J.M.H.3
Maibach, H.I.4
-
20
-
-
0027179153
-
A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice and BCG-RIVM in pTa-pT1 tumors and primary carcinoma in situ of the urinary bladder
-
Witjes, J. A., Van der Meijden, A. P., Witjes, W. P., Doesburg, W., Schaafsma, H. E., Debruyne, F. M. and the Dutch South-East Cooperative Urological Group: A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice and BCG-RIVM in pTa-pT1 tumors and primary carcinoma in situ of the urinary bladder. Eur. J. Cancer, 29A: 1672, 1993.
-
(1993)
Eur. J. Cancer
, vol.29 A
, pp. 1672
-
-
Witjes, J.A.1
Van Der Meijden, A.P.2
Witjes, W.P.3
Doesburg, W.4
Schaafsma, H.E.5
Debruyne, F.M.6
|